Tiago Fauth
Stock Analyst at Raymond James
(4.38)
# 1,312
Out of 5,134 analysts
313
Total ratings
47.5%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by Tiago Fauth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $26 → $14 | $3.01 | +365.12% | 4 | Nov 9, 2026 | |
| BNTC Benitec Biopharma | Initiated Coverage: Buy | $14 | $9.04 | +54.87% | 1 | Oct 23, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $10 | $3.80 | +163.16% | 1 | Oct 23, 2026 | |
| INSM Insmed | Reiterated: Buy | $185 → $173 | $121.16 | +42.79% | 24 | Oct 20, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $84 → $79 | $29.06 | +171.85% | 4 | Oct 20, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $6 → $5 | $0.52 | +861.54% | 2 | Oct 20, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $95 → $106 | $63.49 | +66.96% | 23 | Oct 20, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $86 | $26.15 | +228.87% | 4 | Oct 20, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $700 → $717 | $591.17 | +21.28% | 27 | Oct 20, 2026 | |
| IRLA IRulya Therapeutics | Initiated Coverage: Buy | $72 | $39.80 | +80.90% | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $30.28 | +98.15% | 1 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $19.98 | +130.23% | 1 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $945 | $328.13 | +188.00% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.77 | +238.98% | 1 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $7.25 | +534.48% | 1 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $98 | $78.30 | +25.16% | 18 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $227 → $239 | $241.55 | -1.06% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $10.30 | +94.17% | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $4.13 | +69.49% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $3.13 | n/a | 11 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $31 | $57.41 | n/a | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $21.14 | n/a | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $333 → $395 | $165.04 | n/a | 13 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $65 | $16.08 | n/a | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $4.64 | n/a | 4 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $80.00 | n/a | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $0.697 | n/a | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $9.85 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $70 | $16.14 | n/a | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $89 | $275.39 | n/a | 22 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $57.23 | n/a | 8 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $30.87 | n/a | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $43.31 | n/a | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $26 | $7.77 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $28 | $11.49 | n/a | 9 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $1.17 | n/a | 6 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $34 | $1.04 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $21.60 | n/a | 3 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $4.91 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 → $13 | $2.17 | n/a | 4 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $14 | $1.58 | n/a | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $14 | $8.45 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $340 → $319 | $960.04 | n/a | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $12 → $7 | $34.18 | n/a | 7 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $259 | $465.67 | n/a | 2 | Apr 28, 2021 |
Tonix Pharmaceuticals Holding
Nov 9, 2026
Reiterated: Buy
Price Target: $26 → $14
Current: $3.01
Upside: +365.12%
Benitec Biopharma
Oct 23, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $9.04
Upside: +54.87%
Camp4 Therapeutics
Oct 23, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $3.80
Upside: +163.16%
Insmed
Oct 20, 2026
Reiterated: Buy
Price Target: $185 → $173
Current: $121.16
Upside: +42.79%
Ionis Pharmaceuticals
Oct 20, 2026
Reiterated: Buy
Price Target: $84 → $79
Current: $29.06
Upside: +171.85%
Milestone Pharmaceuticals
Oct 20, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $0.52
Upside: +861.54%
PTC Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $95 → $106
Current: $63.49
Upside: +66.96%
Rapport Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $86
Current: $26.15
Upside: +228.87%
United Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $700 → $717
Current: $591.17
Upside: +21.28%
IRulya Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $72
Current: $39.80
Upside: +80.90%
Oct 2, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $30.28
Upside: +98.15%
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $19.98
Upside: +130.23%
Aug 17, 2026
Reiterated: Buy
Price Target: $945
Current: $328.13
Upside: +188.00%
Aug 13, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.77
Upside: +238.98%
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $7.25
Upside: +534.48%
Jun 17, 2026
Reiterated: Buy
Price Target: $76 → $98
Current: $78.30
Upside: +25.16%
May 6, 2026
Reiterated: Buy
Price Target: $227 → $239
Current: $241.55
Upside: -1.06%
Mar 5, 2026
Reiterated: Buy
Price Target: $26 → $20
Current: $10.30
Upside: +94.17%
Feb 27, 2026
Reiterated: Buy
Price Target: $10 → $7
Current: $4.13
Upside: +69.49%
Sep 4, 2025
Reiterated: Buy
Price Target: $21 → $18
Current: $3.13
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $25 → $31
Current: $57.41
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $101
Current: $21.14
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: $333 → $395
Current: $165.04
Upside: n/a
Jul 9, 2025
Reiterated: Buy
Price Target: $88 → $65
Current: $16.08
Upside: n/a
May 28, 2025
Reiterated: Buy
Price Target: $8 → $7
Current: $4.64
Upside: n/a
May 8, 2025
Reiterated: Buy
Price Target: $91
Current: $80.00
Upside: n/a
Mar 4, 2025
Reiterated: Hold
Price Target: $4 → $3
Current: $0.697
Upside: n/a
Aug 22, 2024
Initiated Coverage: Hold
Price Target: $16
Current: $9.85
Upside: n/a
Jun 17, 2024
Downgraded: Hold
Price Target: $35 → $70
Current: $16.14
Upside: n/a
Jun 13, 2023
Initiated Coverage: Hold
Price Target: $89
Current: $275.39
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $120
Current: $57.23
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $51
Current: $30.87
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $4
Current: $43.31
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $29 → $26
Current: $7.77
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $34 → $28
Current: $11.49
Upside: n/a
Apr 5, 2023
Reiterated: Sell
Price Target: $2
Current: $1.17
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $38 → $34
Current: $1.04
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $7 → $6
Current: $21.60
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $4.91
Upside: n/a
Nov 17, 2022
Downgraded: Hold
Price Target: $33 → $13
Current: $2.17
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $19 → $14
Current: $1.58
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $28 → $14
Current: $8.45
Upside: n/a
Mar 3, 2022
Reiterated: Hold
Price Target: $340 → $319
Current: $960.04
Upside: n/a
Aug 2, 2021
Downgraded: Sell
Price Target: $12 → $7
Current: $34.18
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $265 → $259
Current: $465.67
Upside: n/a